US Stock MarketDetailed Quotes

PTPI Petros Pharmaceuticals

Watchlist

0.3403
-0.0047-1.36%

Trading Aug 26 11:49 ET

3.27MMarket Cap-61P/E (TTM)

Petros Pharmaceuticals Stock Forum

DollarBoy

Aug 6 08:50

Without a reverse split it won't move

$Petros Pharmaceuticals (PTPI.US)$

venda akka

Jul 29 11:46

$Petros Pharmaceuticals (PTPI.US)$ Buy

Trytosaveabit

Jul 29 08:22

News

$Petros Pharmaceuticals (PTPI.US)$ Petros Pharmaceuticals' Pivotal Statistically Significant Self Selection Study Shows Stronger Results With Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (Avanafil)
Accesswire· 1 min ago
Utilization of the Company's proprietary Web App showed improved self-selection utilizing an embedded validated diagnostic questionnaire compared to a live interview furthering the Company's efforts to potentially create ...

Stock Region

Jul 19 12:06

Pharmaceuticals Company Announces Results of Study For OTC Access To ED Drug

Petros Pharmaceuticals' STENDRA® (Avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), commonly referred to as "Petros" or "the Company," has recently announced the results of a pivotal study aimed at enabling over-the-counter (OTC) access to STENDRA® (avanafil). This development represents a step forward in the Compa...

Trytosaveabit

Jul 16 08:18

Update

$Petros Pharmaceuticals (PTPI.US)$ Reuters· 6 mins ago
Petros Pharmaceuticals' Stendra(R) (Avanafil) Pivotal Consumer Self-Selection Study for Over--Counter Access Demonstrates Statistical Significance

Tiggerpepper

Jul 5 08:52

👎🏼👎🏼👎🏼👎🏼👎🏼👎🏼👎🏼👎🏼👎🏼👎🏼👎🏼👎🏼👎🏼

$Petros Pharmaceuticals (PTPI.US)$

Trytosaveabit

May 30 13:28

Just a bit of why I’m bullish here!

$Petros Pharmaceuticals (PTPI.US)$ The successful integration of AI into the company’s self-selection technology for an over-the-counter (OTC) version of Stendra, their prescription erectile dysfunction therapy. The AI component’s ability to significantly reduce error rates in a Human Factors Study suggests a potential for high user accuracy and safety in self-administering the medication, a key concern for OTC medications. Furthermore, Petros is actively ...